Teleport Licenses

Teleport Licenses PACAP Drugs

posted on July 27, 2022

Teleport Pharmaceuticals is developing PACAP glycopeptides for the treatment of ischemic stroke. See more by clicking on the below image. University of Arizona's news release about the PACAP …

Continue Reading about Teleport Licenses PACAP Drugs →

Filed Under: News Tagged With: Glycopeptide Drugs, Polt, Teleport Licenses

Footer CTA

Legal

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Do not sell my personal information.

Settings Accept

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT